Finally, considering the required Pan-IAPs profiling for translational application of IAPs as an attractive therapeutic target, prognostic and diagnostic marker [13,16], we have elucidated the NAIP expression level in different subtypes of lymphoma. The gene discussed is NAIP; the disease is lymphoma.